Health ❯ Healthcare ❯ Regulations

FDA

Drug Approval Process Drug Safety Recalls Drug Recalls Drug Approval Processes Good Manufacturing Practices Drug Shortages Drug Approval Drug Compounding Peptide Injections

FDA Lists Nine Eye-Care Products in Recall Over Sterility Concerns

The manufacturer initiated the action that the FDA classified as Class II, prompting consumers to check lot numbers and stop using matched products.

FDA Elevates Inventia Chlorthalidone Recall to Class II After Failed Dissolution Tests

CDC Links At Least 25 Illnesses to Contaminated Glutathione Injections

FDA Advisory Panel Narrowly Backs Compounding of Six Unapproved Peptides

Viatris Recalls One Lot of Xanax XR Nationwide After Tablets Fail FDA Dissolution Test

FDA Approves Vanda's Bysanti for Schizophrenia and Bipolar I in Adults

Honey Energy Supplement Recalled After FDA Finds Undeclared ED Drug

FDA Eases CMC Rules for Cell and Gene Therapies to Speed Development

FDA Eases Oversight of Wearables and Clinical Decision Support in Final Guidance

FDA Adds Boxed Liver Warning and Limits Elevidys to Ambulatory Boys 4 and Up

Moderna Trims 2025 Forecast as Q3 Loss Narrows and Revenue Beats

FDA Class II Recall Targets 580,000 Prazosin Bottles for Nitrosamine Overages

Louisiana Warns After Two Hospitalizations Tied to Unlicensed Botox Injections

FDA Sends Mass Warnings, Seeks to End 1997 Drug Ad Rule After White House Directive

Khloé Kardashian Shares Mexico Stem Cell Infusion Not Allowed in the U.S.

Tandem Diabetes Announces Urgent Medical Device Correction for t:slim X2 Pumps

FDA Mandates Stricter Safety Labels for Opioids

FDA Ends GLP-1 Drug Shortages, Triggering New Pricing and Coverage Moves

FDA Audit Triggers Nationwide Recall of Over 75,000 Eye Care Products

Nationwide Recall of Eye Care Products Over Sterility Concerns